CBX, the cannabis trading platform, opens up its capital via an STO
CBX, a Geneva-based company founded by Jonas Duclos and Kevin Goetelen, also co-founders of CBD420, is a platform for buying and selling raw materials and products derived from hemp and cannabis.
Based on the premise that regulations in the sector and the level of health safety were more than a little random, the company set out to develop an exchange platform whose main focus is the quality of the product exchanged. Through compliance checks, analyses, transparency certifications and quality labels, the CBX platform aims to be the central tool guaranteeing a controlled environment and the tools to bring transparency from the field to the shop shelf.
«The industry needs to build legitimacy and trust in order to democratize cannabis use. And trust will only exist with relevant testing, certifications and trustworthy labels. I'm proud to present a solution that will enable all industry players to operate in a common market with guaranteed transparency,» says Jonas Duclos.
With almost 4,000 members already, the two partners are now looking for funds to develop their promising and fast-growing business. To this end, they decided to launch an STO to Secured Tokens Offering, to raise funds via blockchain, and open 20% of its capital to the public. Tokenization« enables the company to digitize its shares via blockchain, while satisfying security and transparency requirements... People who buy these tokens will become full shareholders in the company.
To participate in the fundraising, CBX has posted an instruction manual. 2,000 Tokens are on sale at 850 Swiss francs (820 euros) each, and subscriptions will be validated on a first-come, first-served basis. The STO runs until December 31, or until all 2,000 tokens are sold out.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project


You must be logged in to post a comment Login